Artificial intelligence (AI) is bringing quality medical diagnostics to places beyond major hospitals and specialist centres. Across Africa, start-ups are developing tools that analyse medical images, assist with clinical documentation and help healthcare workers identify conditions in areas where specialists are scarce. This represents a promising step towards expanding access to quality healthcare.
However, the distinction between promise and proven impact remains important. AI can help clinicians work faster and extend diagnostic support, but it cannot replace trained health professionals, functional referral systems or reliable medical equipment. Its value depends on whether it performs safely on local patients, fits into clinical workflows and remains available when electricity or internet connectivity fails.
READ ALSO: Youth, Tech, and Sustainability: Africa’s EdTech Startups Leading Transformation
Medical AI systems are designed for specific tasks, including identifying abnormalities on chest X-rays, assisting with mammogram reviews, and measuring foetal growth. Their performance cannot be assumed to transfer from one task, device or patient population to another.
The World Health Organisation (WHO) projects a global shortfall of 11 million health workers by 2030, revised upwards from the 10 million estimate made in 2022. Although the global health workforce now exceeds 70 million, with women accounting for 67%, progress has slowed, masking significant regional disparities. In radiology, sub-Saharan Africa has between zero and three radiologists per million people, compared with more than 100 per million in high-income settings. Ghana, for instance, has only 93 certified radiologists serving a population of 32 million, equivalent to approximately one radiologist for every 344,000 people. These shortages define the context in which AI-powered diagnostic tools must operate.
Across the continent, several companies are exploring different applications of medical AI. Ghana-based MinoHealth AI Labs develops the Moremi suite for medical imaging and clinical decision support, with the company reporting deployments in more than 50 countries. South Africa’s Nexus Intelligence offers chest X-ray analysis software that reportedly processes images in under 45 seconds. Envisionit Deep AI develops RADIFY for occupational health screening, while Morocco’s DeepEcho focuses on AI-assisted ultrasound and maternal healthcare. South African company AI Diagnostics develops digital stethoscope tools for tuberculosis and cardiac screening.
These innovations address distinct clinical needs. A chest X-ray screening tool, an ultrasound measurement aid and a digital stethoscope are not interchangeable, and each requires evidence demonstrating its effectiveness for its intended use.
AI can analyse images within seconds and flag findings that require attention, potentially helping clinicians prioritise urgent cases. However, a rapid software output does not mean a patient receives a diagnosis within seconds. The complete diagnostic pathway still involves image quality, clinical assessment, confirmation, communication and access to treatment.
The safest approach is to use AI as a decision-support tool, with clinicians interpreting its results alongside symptoms, medical history and physical examinations. Faster clinical reviews, expanded diagnostic support beyond specialist hospitals, reduced administrative workloads and improved resilience in low-connectivity settings represent more realistic benefits.
Evidence, Validation and Clinical Safety
Clinical studies demonstrate the potential of AI when properly validated. A multicentre study led by Peking Union Medical College Hospital evaluated an AI model for pulmonary nodule classification, achieving an area under the curve (AUC) of 0.939 in internal testing and 0.943 in external validation.
In a clinical trial involving 400 patients, junior radiologists’ average AUC increased from 0.667 without AI to 0.776 with AI assistance. These findings illustrate how AI can support clinical decision-making, although results from one setting cannot automatically be generalised to African healthcare systems.
For AI tools to be reliable, their development and testing data must reflect the patients, devices and conditions in which they will be used. Differences in disease prevalence, age, imaging equipment, clinical practices and image quality can affect performance. African populations also remain underrepresented in global genomic and molecular datasets.
Local validation must therefore assess accuracy, sensitivity, specificity, failure rates and performance across relevant patient groups. Health authorities must also establish processes for investigating errors and updating or withdrawing underperforming systems.
Infrastructure, Regulation and Trust
AI cannot compensate for clinics lacking functioning equipment, trained staff or access to treatment. Adoption costs include compatible imaging equipment, reliable electricity, staff training, technical support, secure data storage and integration with health records. Limited digital infrastructure, inadequate health data, privacy concerns and underinvestment remain significant barriers to AI adoption across Africa.
Medical AI also requires appropriate regulatory oversight. National medical-device regulations differ across African countries, complicating cross-border deployment. The African Medicines Agency is advancing regulatory harmonisation, while the African Union’s Model Law provides a framework for aligning regulatory processes.
Trust among healthcare professionals is equally important. A multi-country study of 136 West African physicians found that 85.3% believed AI could improve diagnostic accuracy, while 77.9% viewed it as a potential threat to clinical autonomy. Nevertheless, 94.1% expressed willingness to use AI if proven effective. Clinicians highlighted transparency, local validation and clear accountability as essential to building trust.
From Innovation to Better Healthcare
Hospitals and health authorities must evaluate AI tools using practical measures, including diagnostic accuracy, clinician workload, system reliability, referral completion, treatment access, cost and adverse events.
The lasting test is whether these technologies improve patient care under everyday conditions, not merely whether they produce rapid results in demonstrations.
With local validation, clinician oversight, privacy safeguards, reliable maintenance and a clear pathway from detection to treatment, medical AI can become a valuable part of Africa’s healthcare infrastructure. Without these foundations, even promising innovations risk becoming technologies that clinics cannot sustain.
